Liontrust Investment Partners LLP

Position in BEAM — Beam Therapeutics Inc.

CIK 1544204 LONDON, X0

Position in BEAM

as of Jun 30, 2026 · filed Aug 18, 2026 Compact

Position Value

$2,060,058

-$2,663,540 QoQ

Shares Held

60,025

-64.8% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#83

of 274 holders

Holding Since

Jun 2024

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Liontrust Investment Partners LLP holds $22,762,064 across 3 Biotechnology names. BEAM ranks #3 (9.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	25,460	$12,646,745
2	ALNY	Alnylam Pharmaceuticals, Inc.	26,759	$8,055,261
3	BEAM	Beam Therapeutics Inc. This page	60,025	$2,060,058

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,060,058	60,025	-64.8%	Shares	Sole	2026-08-18
2025-12-31	$4,723,598	170,404	+81.5%	Shares	Sole	2026-02-17
2025-03-31	$1,833,671	93,890	-14.8%	Shares	Sole	2025-05-13
2024-12-31	$2,732,464	110,180	+37.7%	Shares	Sole	2025-02-13
2024-09-30	$1,960,000	80,000	0.0%	Shares	Sole	2024-10-16
2024-06-30	$1,874,400	80,000	—	Shares	Sole	2024-07-26
No filing history on record for this holder in this stock.